Telephone
61.3.8379.0100
Address
103-113 Stanley Street West Melbourne, Victoria (VIC) 3003
Description
Acrux Ltd. operates as a pooled development fund that invests in pharmaceutical businesses. The firm develops and commercializes pharmaceutical products using unique technology to administer drugs through the skin. Its products brands include AXIRON, ELLAVIE & EVAMIST and RECUVYRA. The company was founded by Ross Dobinson and Barrie Charles Finnin in 1998 and is headquartered in West Melbourne, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.04 - 0.08
Trade Value (12mth)
AU$2,095.00
1 week
16.28%
1 month
20.48%
YTD
-26.47%
1 year
-30.56%
All time high
4.51673
EPS 3 yr Growth
-95.200%
EBITDA Margin
-33.20%
Operating Cashflow
$1m
Free Cash Flow Return
6.40%
ROIC
-7.00%
Interest Coverage
N/A
Quick Ratio
4.10
Shares on Issue (Fully Dilluted)
286m
HALO Sector
Healthcare
Next Company Report Date
23-Aug-24
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
31 October 06 |
CEO Presentation
×
CEO Presentation |
31 March 23 |
Notification of cessation of securities - ACR
×
Notification of cessation of securities - ACR |
31 March 23 |
Application for quotation of securities - ACR
×
Application for quotation of securities - ACR |
31 March 23 |
Appendix 3Y Brooke
×
Appendix 3Y Brooke |
31 March 23 |
Appendix 3Y Oldham
×
Appendix 3Y Oldham |
30 November 10 |
2010 AGM Presentations
×
2010 AGM Presentations |
30 May 22 |
Successful patent litigation outcome
×
Successful patent litigation outcome |
30 January 23 |
Quarterly Activities / Appendix 4C Cashflow Report
×
Quarterly Activities / Appendix 4C Cashflow Report |
30 August 23 |
Application for quotation of securities - ACR
×
Application for quotation of securities - ACR |
30 August 23 |
Appendix 3Y Brumley
×
Appendix 3Y Brumley |
30 August 23 |
Appendix 3Y Dobinson
×
Appendix 3Y Dobinson |
30 August 23 |
Appendix 3Y Brooke
×
Appendix 3Y Brooke |
30 August 22 |
Application for quotation of securities - ACR
×
Application for quotation of securities - ACR |
30 August 22 |
Appendix 3Y - Brumley
×
Appendix 3Y - Brumley |
30 August 22 |
Notification of cessation of securities - ACR
×
Notification of cessation of securities - ACR |
29 September 06 |
Notice of Annual General Meeting
×
Notice of Annual General Meeting |
29 September 06 |
2006 Annual Report
×
2006 Annual Report |
29 November 23 |
Address of Chair and CEO to AGM
×
Address of Chair and CEO to AGM |
29 November 23 |
Results of AGM
×
Results of AGM |
28 September 07 |
2007 Annual Report
×
2007 Annual Report |
28 October 22 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
28 October 22 |
Application for quotation of securities - ACR
×
Application for quotation of securities - ACR |
28 October 22 |
Appendix 3Y Ross Dobinson
×
Appendix 3Y Ross Dobinson |
28 October 22 |
Appendix 3Y Geoff Brooke
×
Appendix 3Y Geoff Brooke |
28 November 19 |
Acrux Investor Presentation
×
Acrux Investor Presentation |
28 November 19 |
Annual General Meeting Results
×
Annual General Meeting Results |
28 June 22 |
Updated Corporate Policy - Code of Conduct
×
Updated Corporate Policy - Code of Conduct |
28 April 14 |
Investor Presentation 28 April 2014
×
Investor Presentation 28 April 2014 |
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.